|
|
Blood, 1 May 2007, Vol. 109, No. 9, pp. 3794-3802.
Prepublished online as a Blood First Edition Paper on January 3, 2007; DOI 10.1182/blood-2005-09-010116.
Next Article 
Submitted September 28, 2005
Accepted December 25, 2006
An essential role for IL-17 in preventing pathogen-
initiated bone destruction: recruitment of neutrophils
to inflamed bone requires IL-17 receptor-dependent
signals
Jeffrey J Yu, Matthew J Ruddy, Grace C Wong, Cornelia Sfintescu, Pamela J Baker, Jeffrey B Smith, Richard T Evans, and Sarah L Gaffen*
Department of Microbiology and Immunology, School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, Buffalo, NY, United States
Department of Oral Biology, School of Dental Medicine, University at Buffalo, SUNY, Buffalo, NY, United States
Department of Biology, Bates College, Lewiston, ME, United States
Department of Pediatrics, David Geffen School of Medicine and Mattel Children's Hospital at UCLA, Los Angeles, CA, United States
* Corresponding author; email: sgaffen{at}buffalo.edu.
IL-17 and its receptor are founding members of a novel family of inflammatory cytokines. IL-17 plays a pathogenic role in rheumatoid arthritis (RA)-associated bone destruction. However, IL-17 is also an important regulator of host defense through granulopoiesis and neutrophil trafficking. Therefore, it was not obvious whether IL-17 would play a pathogenic or protective role in pathogen-initiated bone loss. The most common form of infection-induced bone destruction occurs in periodontal disease (PD). In addition to causing significant morbidity, PD is a risk factor for atherosclerotic heart disease and COPD. Similar to RA, bone destruction in PD is caused by the immune response. However, neutrophils provide critical anti-microbial defense against periodontal organisms. Since IL-17 is bone destructive in RA but a key regulator of neutrophils, we examined its role in inflammatory bone loss induced by the oral pathogen Porphyromonas gingivalis in IL-17RA-deficient mice. These mice showed enhanced periodontal bone destruction, suggesting a bone-protective role for IL-17, reminiscent of a neutrophil deficiency. Although IL-17RA-deficient neutrophils functioned normally ex vivo, IL-17RAKO mice exhibited reduced serum chemokine levels and concomitantly reduced neutrophil migration to bone. CXCR2KO mice were also highly susceptible to alveolar bone loss; interestingly, these mice also suggested a role for chemokines in maintaining normal bone homeostasis. These results indicate a non-redundant role for IL-17 in mediating host defense via neutrophil mobilization.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. S. Kap, M. van Meurs, N. van Driel, G. Koopman, M.-J. Melief, H. P.M. Brok, J. D. Laman, and B. A. 't Hart
A Monoclonal Antibody Selection for Immunohistochemical Examination of Lymphoid Tissues From Non-human Primates
J. Histochem. Cytochem.,
December 1, 2009;
57(12):
1159 - 1167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhou, Q. Chen, J. Moore, J. K. Kolls, S. Halperin, and J. Wang
Critical Role of the Interleukin-17/Interleukin-17 Receptor Axis in Regulating Host Susceptibility to Respiratory Infection with Chlamydia Species
Infect. Immun.,
November 1, 2009;
77(11):
5059 - 5070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. S. Algood, S. S. Allen, M. K. Washington, R. M. Peek Jr., G. G. Miller, and T. L. Cover
Regulation of Gastric B Cell Recruitment Is Dependent on IL-17 Receptor A Signaling in a Model of Chronic Bacterial Infection
J. Immunol.,
November 1, 2009;
183(9):
5837 - 5846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhang, V. C. Kyttaris, and G. C. Tsokos
The Role of IL-23/IL-17 Axis in Lupus Nephritis
J. Immunol.,
September 1, 2009;
183(5):
3160 - 3169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fang, X. Zhang, T. Miwa, and W.-C. Song
Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production
Blood,
July 30, 2009;
114(5):
1005 - 1015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Onan, E. H. Allan, J. M. W. Quinn, J. H. Gooi, S. Pompolo, N. A. Sims, M. T. Gillespie, and T. J. Martin
The Chemokine Cxcl1 Is a Novel Target Gene of Parathyroid Hormone (PTH)/PTH-Related Protein in Committed Osteoblasts
Endocrinology,
May 1, 2009;
150(5):
2244 - 2253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lopez Kostka, S. Dinges, K. Griewank, Y. Iwakura, M. C. Udey, and E. von Stebut
IL-17 Promotes Progression of Cutaneous Leishmaniasis in Susceptible Mice
J. Immunol.,
March 1, 2009;
182(5):
3039 - 3046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Conti, F. Shen, N. Nayyar, E. Stocum, J. N. Sun, M. J. Lindemann, A. W. Ho, J. H. Hai, J. J. Yu, J. W. Jung, et al.
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
J. Exp. Med.,
February 16, 2009;
206(2):
299 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Herbert, T. Orekov, C. Perkins, and F. D. Finkelman
IL-10 and TGF-{beta} Redundantly Protect against Severe Liver Injury and Mortality during Acute Schistosomiasis
J. Immunol.,
November 15, 2008;
181(10):
7214 - 7220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.L. Gaffen and G. Hajishengallis
A New Inflammatory Cytokine on the Block: Re-thinking Periodontal Disease and the Th1/Th2 Paradigm in the Context of Th17 Cells and IL-17
Journal of Dental Research,
September 1, 2008;
87(9):
817 - 828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Yu, M. J. Ruddy, H. R. Conti, K. Boonanantanasarn, and S. L. Gaffen
The Interleukin-17 Receptor Plays a Gender-Dependent Role in Host Protection against Porphyromonas gingivalis-Induced Periodontal Bone Loss
Infect. Immun.,
September 1, 2008;
76(9):
4206 - 4213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sasaki, N. Suzuki, R. Kent Jr., N. Kawashima, J. Takeda, and P. Stashenko
T Cell Response Mediated by Myeloid Cell-Derived IL-12 Is Responsible for Porphyromonas gingivalis-Induced Periodontitis in IL-10-Deficient Mice
J. Immunol.,
May 1, 2008;
180(9):
6193 - 6198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hajishengallis, M.-A. K. Shakhatreh, M. Wang, and S. Liang
Complement Receptor 3 Blockade Promotes IL-12-Mediated Clearance of Porphyromonas gingivalis and Negates Its Virulence In Vivo
J. Immunol.,
August 15, 2007;
179(4):
2359 - 2367.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|